American Heart Association collaborates with Amazon Web Services for precision medicine
The American Heart Association is partnering with Amazon Web Services, in an effort to further cardiovascular medicine with AWS cloud technology. It's part of a new initiative of AHA Institute for Precision Cardiovascular Medicine, the group announced this past week.
The collaborative goal is to foster research, which will expand cardiovascular science and practice through precision medicine. According to the announcement, the effort will pool genetic data and patient lifestyle and environment that will be aggregated and analyzed by AHA researchers to improve care and reduce overall healthcare costs.
"AWS is uniquely positioned to provide scalable, cost-efficient solutions for the scientific community, while delivering the industry-shaping technology and high-performance computing necessary to facilitate the most demanding research projects," Teresa Carlson, vice president of the Worldwide Public Sector for AWS.
In addition to its AWS collaboration, AHA also announced its launching a new Data Grant Portfolio. AHA will award 14 grants throughout the year to support data mining, methods validation, innovative development and fellowships and will encourage collaboration among biomedical researchers.
Grant recipients will receive funding from AHA to cover research expenses, including salaries, and cash incentives will be offered to grantees in each area for providing the best ideas to innovate data discovery.
AHA allocated $30 million over the next five years to launch the institute and will spearhead a fundraising campaign to generate an additional $100 - $200 million for further advances.
"The promise of precision cardiovascular medicine and care can be realized when research and technology come together to deliver new insights," AHA CEO Nancy Brown, said in a statement.
"The AHA and AWS collaboration will unite the global research community to accelerate discovery in cardiovascular health and usher in a new era of tailored prevention and treatment that will help patients and lessen the global burden of cardiovascular disease," she added.